期刊文献+

中国序贯疗法与三联疗法治疗幽门螺杆菌感染荟萃分析 被引量:53

Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in Chinese patients:a meta-analysis
在线阅读 下载PDF
导出
摘要 目的:系统评价中国序贯疗法与三联疗法治疗幽门螺杆菌(Hpylori)感染的疗效及不良反应的差异.方法:利用中文数据库,根据纳入标准入选中国序贯疗法与三联疗法根除Hpylori的随机对照临床试验.提取患者的基本资料、研究质量、Hpylori根除率和不良反应发生率等相关数据.比较序贯疗法和7日或10日三联疗法的Hpylori根除率和不良反应发生率,计算相对危险度(Relativerisk,RR)和95%CI.运用漏斗图评价出版偏倚.结果:纳入了9项随机对照研究,共835例患者.序贯疗法、7日及10日三联疗法的总Hpylori根除率分别为92.0%、73.7%和84.5%(P=0.002).序贯疗法分别与7日或10日三联疗法比较,RR分别为1.23(95%CI:1.14-1.33)和1.12(95%CI:1.02-1.23).不良反应发生率无明显差异.结论:中国根除Hpylori使用序贯疗法明显优于7日和10日三联疗法,不良反应发生率无差异. AIM:To systematically review the differences in efficacy and incidence of adverse reactions between sequential therapy and standard triple therapy for the eradication of Helicobacter pylori (H pylori)infection in Chinese patients.METHODS:A search of Chinese databases was conducted by two independent reviewers to identify randomized controlled trials(RCT)comparing sequential therapy with standard 7-day and 10-day triple therapies in the treatment of H pylori infection.The patients’clinical data, study quality,H pylori eradication rate and the incidence rate of adverse reactions were compared between sequential therapy and standard 7-day and 10-day standard triple therapies in the treatment of H pylori infection.The relative risk ratio(RR)with 95%confidence intervals(CI) was calculated.The funnel plots was used to estimate publication bias.RESULTS:A total of 9 studies involving 835 subjects were identified.The eradication rates of sequential therapy and standard 7-day and 10-day triple therapies were 92.0%,73.7%and 84.5%,respectively.Pooled estimates showed superiority of sequential therapy over 7-day triple regimen with RR of 1.23(95%CI:1.14-1.33), and over 10-day triple regimen with RR of 1.12 (95%CI:1.02-1.23).The incidence rate of adverse reactions was comparable between the two therapies. CONCLUSION:Sequential therapy appears superior to standard triple therapy for eradication of H pylori infection in Chinese patients.No significant difference is noted in the incidence rate of adverse reactions between the two therapies.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第32期3365-3369,共5页 World Chinese Journal of Digestology
关键词 幽门螺杆菌 序贯疗法 三联疗法 根除率 荟萃分析 Helicobacter pylori Sequential therapy Triple therapy Eradication rate Meta-analysis
  • 相关文献

参考文献21

二级参考文献79

共引文献706

同被引文献487

引证文献53

二级引证文献285

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部